Focused Wealth Management, Inc - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 129 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.8%.

Links
Filings
External links
Quarter-by-quarter ownership
Focused Wealth Management, Inc ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$0–3500.0%0.00%–
Q3 2018$0–3500.0%0.00%–
Q2 2018$0
-100.0%
3500.0%0.00%–
Q1 2018$1,0000.0%3500.0%0.00%–
Q4 2017$1,000–350–0.00%–
 Download
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q1 2018
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders